Astrazeneca Ceo
- All
- News
- Videos
-
Not Perfect, But Saves Lives, Says AstraZeneca CEO On Covid Vaccine
AstraZeneca's COVID-19 vaccine is not perfect, but will have a big impact on the pandemic, its chief executive predicted on Thursday, as the drugmaker pledged to double supplies to more than 200 million doses per month by April.
-
COVID-19 Vaccine Should Work Against Severe Disease, Says AstraZeneca CEO
AstraZeneca's Chief Executive said on Tuesday that the results of a study showing its COVID-19 vaccine had little effect against mild disease were concerning but stressed that it should work against severe forms.
-
Not Selling EU Vaccine Doses To Other Countries For Profit: AstraZeneca Chief
AstraZeneca's CEO insisted Tuesday that the company was not selling vaccines ordered by the European Union to other countries at a profit, after delayed orders sparked fury from EU leaders.
-
Oxford Vaccine Will Protect 95 Per Cent, Says AstraZeneca CEO: Report
The Oxford coronavirus vaccine will "protect 95 per cent of patients" and is "as effective as the Pfizer and Moderna" alternatives, Pascal Soriot, the chief executive of AstraZeneca, told British daily The Sunday Times
-
Ranbaxy Still Has Exclusive Rights for Nexium Generic: CEO
Ranbaxy Laboratories still has exclusive rights to the launch of AstraZeneca's heartburn drug Nexium in the United States, it said on Tuesday, despite regulatory concern over the manufacturing process.
-
Pfizer Presses AstraZeneca Case as CEO Faces UK Grilling
US drugmaker Pfizer pressed the scientific case for its controversial plan to acquire AstraZeneca on Monday as its chief executive prepared for a grilling from British lawmakers.
-
AstraZeneca CEO to step down as Q1 profit plunges
The U.K. drug maker's chief executive, David Brennan is going to retire as the company reported a 44% drop in the Q1 net profit. CFO Simon Loweth will step up as interim CEO until a permanent successor is appointed.
-
Not Perfect, But Saves Lives, Says AstraZeneca CEO On Covid Vaccine
AstraZeneca's COVID-19 vaccine is not perfect, but will have a big impact on the pandemic, its chief executive predicted on Thursday, as the drugmaker pledged to double supplies to more than 200 million doses per month by April.
-
COVID-19 Vaccine Should Work Against Severe Disease, Says AstraZeneca CEO
AstraZeneca's Chief Executive said on Tuesday that the results of a study showing its COVID-19 vaccine had little effect against mild disease were concerning but stressed that it should work against severe forms.
-
Not Selling EU Vaccine Doses To Other Countries For Profit: AstraZeneca Chief
AstraZeneca's CEO insisted Tuesday that the company was not selling vaccines ordered by the European Union to other countries at a profit, after delayed orders sparked fury from EU leaders.
-
Oxford Vaccine Will Protect 95 Per Cent, Says AstraZeneca CEO: Report
The Oxford coronavirus vaccine will "protect 95 per cent of patients" and is "as effective as the Pfizer and Moderna" alternatives, Pascal Soriot, the chief executive of AstraZeneca, told British daily The Sunday Times
-
Ranbaxy Still Has Exclusive Rights for Nexium Generic: CEO
Ranbaxy Laboratories still has exclusive rights to the launch of AstraZeneca's heartburn drug Nexium in the United States, it said on Tuesday, despite regulatory concern over the manufacturing process.
-
Pfizer Presses AstraZeneca Case as CEO Faces UK Grilling
US drugmaker Pfizer pressed the scientific case for its controversial plan to acquire AstraZeneca on Monday as its chief executive prepared for a grilling from British lawmakers.
-
AstraZeneca CEO to step down as Q1 profit plunges
The U.K. drug maker's chief executive, David Brennan is going to retire as the company reported a 44% drop in the Q1 net profit. CFO Simon Loweth will step up as interim CEO until a permanent successor is appointed.
